Cancer research organization City of Hope has co-led a study to show that characterizing genetic material close to chromosomes predicts how mutated, cancer-causing genes reprogram DNA and alter the tumor microenvironment. City of Hope said…
Continue Reading
What You Should Know:
– Biostate AI, an innovator at the intersection of artificial intelligence and RNA sequencing raises $12M in Series A funding spearheaded by Accel, with participation from Gaingels, Mana Ventures, InfoEdge Ventures,…
Continue Reading
What You Should Know:
– Immunai, a leading AI biotech company specializing in mapping the human immune system and the Parker Institute for Cancer Immunotherapy (PICI), a collaborative consortium of the world’s leading immuno-oncology experts,…
Continue Reading
Drug design and development company Isomorphic Labs announced it raised $600 million dollars in its first external funding round.Thrive Capital led the round with participation from GV (Google Ventures) and existing investor Alphabet.
WHAT IT…
Building accurate prediction models and identifying predictive biomarkers for treatment response in Muscle-Invasive Bladder Cancer (MIBC) are essential for improving patient survival but remain challenging due to tumor heterogeneity, despite numerous related studies. To…
Continue Reading
Sai Bhamidipati, Pharmaceutical Regulatory Affairs Consultant
The biopharmaceutical landscape is transforming with the advent of advanced therapeutics, including mRNA vaccines, gene therapies, and personalized medicine. These innovative treatments offer unprecedented opportunities to address complex diseases….
Continue Reading
What You Should Know:
– Converge Bio, a generative AI platform for accelerated drug discovery and development, today announced it has raised $5.5 million in seed funding, led by TLV Partners.
– Converge Bio’s platform uses large language…
Continue Reading
Global clinical-stage biotech company HuidaGene Therapeutics has received FDA clearance to move forward with its application for its investigational drug, a CRISPR/Cas13 RNA-editing therapy to treat neovascular age-related macular degeneration (nAMD) dubbed HG202, developed…
Continue Reading
What You Should Know:
– miRoncol, a medtech startup, has announced the completion of proof-of-concept studies for a groundbreaking multi-cancer early detection blood test.
– The test utilizes microRNA analysis and machine learning, two technologies recognized…
Continue Reading
What You Should Know:
– Sheba Medical Center, a leading Israeli hospital renowned for its medical innovation, and its innovation arm, ARC Innovation, have announced a collaborative research agreement with Mana.bio.
– The partnership aims to…
Continue Reading
